Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance-Reference-Cited by-同舟云学术

Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance

Published:2021-12-15 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hlady Ryan A.¹^ORCID,Zhao Xia¹,El Khoury Louis Y.¹,Luna Aesis²,Pham Kien²,Wu Qunfeng³,Lee Jeong‐Heon⁴^ORCID,Pyrsopoulos Nikolaos T.⁵,Liu Chen²,Robertson Keith D.¹^ORCID

Affiliation:

1. Department of Molecular Pharmacology and Experimental Therapeutics Mayo Clinic Rochester Minnesota USA

2. Department of Pathology Yale School of Medicine New Haven Connecticut USA

3. Department of Pathology and Laboratory Medicine New Jersey Medical School Rutgers The State University of New Jersey Newark New Jersey USA

4. Department of Biochemistry and Molecular Biology Mayo Clinic Rochester Minnesota USA

5. Department of Medicine Rutgers New Jersey Medical School Newark New Jersey USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

American Association for the Study of Liver Diseases

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32111

Reference32 articles.

1. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

2. Hepatocellular Carcinoma

3. HCV eradication induced by direct‐acting antiviral agents reduces the risk of hepatocellular carcinoma;Ioannou GN;J Hepatol,2017

4. The histone H4 acetyltransferase MOF uses a C2HC zinc finger for substrate recognition

5. Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact;Hepatobiliary Surgery and Nutrition;2024-08

2. Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals;Current Opinion in Virology;2024-08

3. Epigenetic heterogeneity hotspots in human liver disease progression;Hepatology;2024-07-19

4. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication;Clinical and Molecular Hepatology;2024-07-01

5. After the Storm: Persistent Molecular Alterations Following HCV Cure;International Journal of Molecular Sciences;2024-06-27